Peripheral Blood Progenitor Cell Transplantation: Clinical, Practical, and Economic Considerations
- 1 January 1994
- journal article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 3 (4) , 331-348
- https://doi.org/10.1089/scd.1.1994.3.331
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapyBlood, 1993
- Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineageBlood, 1992
- Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte- macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatinBlood, 1992
- Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomaBlood, 1991
- Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patientsBlood, 1991
- Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purgingBlood, 1990
- Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factorBlood, 1989
- High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphomaBlood, 1989
- Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapyBlood, 1988
- Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphomaBlood, 1986